| abstract |
The invention features polypeptides comprising soluble alkaline phosphatase, mutants, fragments, fusion proteins thereof, and methods of use thereof, for the treatment of bone mineralization disorders, such as hypophosphatasia (HPP) and symptoms thereof. These polypeptides include soluble alkaline phosphatase (sALP) or fragments thereof, which are derived from naturally occurring alkaline phosphatase (ALP). |